Lung group 2 innate lymphoid cells differentially depend on local IL-7 for their distribution, activation, and maintenance in innate and adaptive immunity-mediated airway inflammation.


Journal

International immunology
ISSN: 1460-2377
Titre abrégé: Int Immunol
Pays: England
ID NLM: 8916182

Informations de publication

Date de publication:
07 Nov 2023
Historique:
received: 04 05 2022
accepted: 24 07 2023
medline: 13 11 2023
pubmed: 26 7 2023
entrez: 26 7 2023
Statut: ppublish

Résumé

Interleukin-7 (IL-7) is a cytokine critical for the development and maintenance of group 2 innate lymphoid cells (ILC2s). ILC2s are resident in peripheral tissues such as the intestine and lung. However, whether IL-7 produced in the lung plays a role in the maintenance and function of lung ILC2s during airway inflammation remains unknown. IL-7 was expressed in bronchoalveolar epithelial cells and lymphatic endothelial cells (LECs). To investigate the role of local IL-7 in lung ILC2s, we generated two types of IL-7 conditional knockout (IL-7cKO) mice: Sftpc-Cre (SPC-Cre) IL-7cKO mice specific for bronchial epithelial cells and type 2 alveolar epithelial cells and Lyve1-Cre IL-7cKO mice specific for LECs. In steady state, ILC2s were located near airway epithelia, although lung ILC2s were unchanged in the two lines of IL-7cKO mice. In papain-induced airway inflammation dependent on innate immunity, lung ILC2s localized near bronchia via CCR4 expression, and eosinophil infiltration and type 2 cytokine production were reduced in SPC-Cre IL-7cKO mice. In contrast, in house dust mite (HDM)-induced airway inflammation dependent on adaptive immunity, lung ILC2s localized near lymphatic vessels via their CCR2 expression 2 weeks after the last challenge. Furthermore, lung ILC2s were decreased in Lyve1-Cre IL-7cKO mice in the HDM-induced inflammation because of decreased cell survival and proliferation. Finally, administration of anti-IL-7 antibody attenuated papain-induced inflammation by suppressing the activation of ILC2s. Thus, this study demonstrates that IL-7 produced by bronchoalveolar epithelial cells and LECs differentially controls the activation and maintenance of lung ILC2s, where they are localized in airway inflammation.

Identifiants

pubmed: 37493250
pii: 7231240
doi: 10.1093/intimm/dxad029
doi:

Substances chimiques

Interleukin-7 0
Papain EC 3.4.22.2
Cytokines 0
Interleukin-33 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

513-530

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 20H03501
Organisme : Takeda Science Foundation
Organisme : Shimizu Foundation for Immunology and Neuroscience
Organisme : Kyoto University

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of The Japanese Society for Immunology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Daichi Takami (D)

Department of Virus Research, Laboratory of Immune Regulation, Institute for Life and Medical Sciences, Kyoto University, Kyoto 606-8507, Japan.
Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.

Shinya Abe (S)

Department of Virus Research, Laboratory of Immune Regulation, Institute for Life and Medical Sciences, Kyoto University, Kyoto 606-8507, Japan.

Akihiro Shimba (A)

Department of Virus Research, Laboratory of Immune Regulation, Institute for Life and Medical Sciences, Kyoto University, Kyoto 606-8507, Japan.
Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.

Takuma Asahi (T)

Department of Virus Research, Laboratory of Immune Regulation, Institute for Life and Medical Sciences, Kyoto University, Kyoto 606-8507, Japan.
Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.

Guangwei Cui (G)

Department of Virus Research, Laboratory of Immune Regulation, Institute for Life and Medical Sciences, Kyoto University, Kyoto 606-8507, Japan.

Shizue Tani-Ichi (S)

Department of Virus Research, Laboratory of Immune Regulation, Institute for Life and Medical Sciences, Kyoto University, Kyoto 606-8507, Japan.
Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.

Takahiro Hara (T)

Department of Virus Research, Laboratory of Immune Regulation, Institute for Life and Medical Sciences, Kyoto University, Kyoto 606-8507, Japan.

Keishi Miyata (K)

Department of Molecular Genetics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan.

Masashi Ikutani (M)

Graduate School of Integrated Sciences for Life, Hiroshima University, Higashi-Hiroshima 739-8511, Japan.

Kiyoshi Takatsu (K)

Toyama Prefectural Institute for Pharmaceutical Research, Toyama 930-8501, Japan.

Yuichi Oike (Y)

Department of Molecular Genetics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan.

Koichi Ikuta (K)

Department of Virus Research, Laboratory of Immune Regulation, Institute for Life and Medical Sciences, Kyoto University, Kyoto 606-8507, Japan.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
C-Reactive Protein Humans Biomarkers Inflammation
Humans Immune Checkpoint Inhibitors Lung Neoplasms Prognosis Inflammation

Classifications MeSH